174 related articles for article (PubMed ID: 33078595)
21. Adjuvant carboplatin and paclitaxel with "sandwich" method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution.
Chinnadurai A; Breadner D; Baloush Z; Lohmann AE; Black M; D'Souza D; Welch S
J Gynecol Oncol; 2024 Mar; 35(2):e16. PubMed ID: 37921600
[TBL] [Abstract][Full Text] [Related]
22. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
23. Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.
McEachron J; Chen YJ; Zhou N; Kao J; Gorelick C; Kanis MJ; Lee YC
Int J Gynecol Cancer; 2022 Nov; 32(11):1402-1409. PubMed ID: 36343971
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
[TBL] [Abstract][Full Text] [Related]
25. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
26. Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
Lan C; Huang X; Huang Q; Wang Y; Gu H; Li Y; Liu J
Int J Gynecol Cancer; 2015 Oct; 25(8):1445-52. PubMed ID: 26397067
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Features of Recurrent Endometrial Cancer in Japan: Chemotherapy Instead of Radiotherapy as Postoperative Adjuvant Treatment.
Iwase H; Furukawa S; Hirasawa T; Asai S; Ohara T; Hosonuma S; Endo S; Tazo Y; Sato H; Takada T; Arai M; Ikeda M; Shida M; Yoshioka N; Tozawa-Ono A; Suzuki N; Mikami M; Onda T
Int J Gynecol Cancer; 2018 Oct; 28(8):1616-1623. PubMed ID: 30095709
[TBL] [Abstract][Full Text] [Related]
28. Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.
Wilkinson-Ryan I; Binder PS; Pourabolghasem S; Al-Hammadi N; Fuh K; Hagemann A; Thaker P; Schwarz J; Grigsby P; Mutch D; Powell M
Gynecol Oncol; 2014 Jul; 134(1):24-8. PubMed ID: 24823648
[TBL] [Abstract][Full Text] [Related]
29. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
Ko EM; Brensinger CM; Cory L; Giuntoli RL; Haggerty AF; Latif NA; Aviles D; Martin L; Morgan MA; Lin LL
Gynecol Oncol; 2020 Nov; 159(2):394-401. PubMed ID: 32800655
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
Young MR; Higgins SA; Ratner E; Yu JB; Mani S; Silasi DA; Azodi M; Rutherford T; Schwartz PE; Damast S
Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409
[TBL] [Abstract][Full Text] [Related]
31. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
[TBL] [Abstract][Full Text] [Related]
32. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
33. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
Xu MJ; Chu C; Rubin S; Lin LL
Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
[TBL] [Abstract][Full Text] [Related]
34. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
[TBL] [Abstract][Full Text] [Related]
35. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
36. Patterns of adjuvant therapy for endometrial cancer: single institutional experience in Thailand.
Tangjitgamol S; Khunnarong J; Katanyoo K; Srijaipracharoen S; Thavaramara T; Pataradool K
Int J Gynecol Cancer; 2015 May; 25(4):665-72. PubMed ID: 25664438
[TBL] [Abstract][Full Text] [Related]
37. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
[TBL] [Abstract][Full Text] [Related]
38. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
[TBL] [Abstract][Full Text] [Related]
39. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]